Preservative challenge performance and skin-microbiome impact answer different questions. They should be evaluated in parallel instead of collapsed into one score or one marketing label.
The product and the skin ask different questions
Product preservation asks whether a formula controls contamination and maintains quality through manufacture, storage and use. Microbiome assessment asks what happens to microbial composition, barrier markers and immune-related endpoints after exposure.
Passing a challenge test does not answer the second question. A skin-side observation also cannot replace preservation evidence for the packaged product.
The objectives can conflict
Water activity, pH, packaging, raw-material bioburden and preservative distribution shape product protection. Exposure level, contact time, site, baseline microbiome and sampling method shape the biological reading.
A single ingredient label cannot describe both systems. The development objective is a condition window in which product control remains robust while the intended skin-side endpoints remain acceptable.
Use a parallel test matrix
Start with preservative efficacy, package-use simulation and stability controls. In a separate but linked matrix, define the skin model, exposure, microbiome method, barrier endpoints and biological controls.
Compare complete formulas, not only isolated preservatives. Report uncertainty openly and avoid immune, therapeutic or universal microbiome-friendly language unless the exact finished product and target market support it.
Evidence and use boundary
English-edited from the approved GreenDee Muzi science digest. The framework does not establish that a preservative system improves immunity or is universally microbiome-friendly.